Cargando…

Recent Analytical Advances for Decoding Metabolic Reprogramming in Lung Cancer

Lung cancer is the leading cause of cancer-related death worldwide. Metabolic reprogramming is a fundamental trait associated with lung cancer development that fuels tumor proliferation and survival. Monitoring such metabolic pathways and their intermediate metabolites can provide new avenues concer...

Descripción completa

Detalles Bibliográficos
Autor principal:	Almalki, Atiah H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609104/ https://www.ncbi.nlm.nih.gov/pubmed/37887362 http://dx.doi.org/10.3390/metabo13101037

Ejemplares similares

Recent advancements in bariatric/metabolic surgery
por: Lee, Wei‐Jei, et al.
Publicado: (2017)

Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry
por: Almalki, Atiah H., et al.
Publicado: (2023)

Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer
por: Galbraith, Madeline, et al.
Publicado: (2022)

Recent advances microRNAs and metabolic reprogramming in colorectal cancer research
por: Xiong, Bin, et al.
Publicado: (2023)

Tumor metabolic reprogramming in lung cancer progression
por: Li, Xin, et al.
Publicado: (2022)

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
por: Xu, Ruiyuan, et al.
Publicado: (2020)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Recent Advances in Understanding Peripheral Taste Decoding I: 2010 to 2020
por: Jang, Jea Hwa, et al.
Publicado: (2021)

Fatty Acids in Membranes as Homeostatic, Metabolic and Nutritional Biomarkers: Recent Advancements in Analytics and Diagnostics
por: Ferreri, Carla, et al.
Publicado: (2016)

Recent Advances: Decoding Alzheimer’s Disease With Stem Cells
por: Fang, Yi, et al.
Publicado: (2018)

Decoding Metabolic Reprogramming in Plants under Pathogen Attacks, a Comprehensive Review of Emerging Metabolomics Technologies to Maximize Their Applications
por: Serag, Ahmed, et al.
Publicado: (2023)

Recent Advances in Analytical Approaches for Glycan and Glycopeptide Quantitation
por: Delafield, Daniel G., et al.
Publicado: (2021)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
por: Jin, Jing, et al.
Publicado: (2020)

Decoding and reprogramming fungal iterative nonribosomal peptide synthetases
por: Yu, Dayu, et al.
Publicado: (2017)

Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives
por: Yu, Zhuoya, et al.
Publicado: (2022)

Experimental and Computational Approaches to Direct Cell Reprogramming: Recent Advancement and Future Challenges
por: Gam, Rihab, et al.
Publicado: (2019)

Advances in the role of m(6)A RNA modification in cancer metabolic reprogramming
por: Han, Xiu, et al.
Publicado: (2020)

Recent Metabolomics Analysis in Tumor Metabolism Reprogramming
por: Han, Jingjing, et al.
Publicado: (2021)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

Recent Advances in Perioperative Immunotherapies in Lung Cancer
por: Fukuda, Shota, et al.
Publicado: (2023)

Recent advances in diagnostic technologies in lung cancer
por: Park, Hye Jung, et al.
Publicado: (2020)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Evolutionary Origins of Metabolic Reprogramming in Cancer
por: García-Sancha, Natalia, et al.
Publicado: (2022)

Macrophage metabolic reprogramming during chronic lung disease
por: Ogger, Patricia P., et al.
Publicado: (2020)

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
por: Eltayeb, Kamal, et al.
Publicado: (2022)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Recent Analytical Approaches for the Study of Bioavailability and Metabolism of Bioactive Phenolic Compounds
por: Fernández-Ochoa, Álvaro, et al.
Publicado: (2022)

Recent advances in lung transplantation
por: Meyer, Keith C
Publicado: (2018)

Meta-analytic decoding of the cortical gradient of functional connectivity
por: Peraza, Julio A., et al.
Publicado: (2023)

Recent advances in early stage lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Reprogramming of fatty acid metabolism in cancer
por: Koundouros, Nikos, et al.
Publicado: (2019)

Recent Advances in the Analytical Stress Field Solutions for Radiused Notches in Orthotropic Solids
por: Pontefisso, Alessandro, et al.
Publicado: (2023)

Recent Advances in the DNA-Mediated Multi-Mode Analytical Methods for Biological Samples
por: Huang, Lu, et al.
Publicado: (2023)

Recent Advances in Analytical Methods for Determination of Polyphenols in Tea: A Comprehensive Review
por: Sun, Mu-Fang, et al.
Publicado: (2022)

Recent advances in aptamer applications for analytical biochemistry
por: Zon, Gerald
Publicado: (2022)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tiernu2qnvhpgh6h8je0d24si